4/A//SEC Filing
Mayer Arie 4/A
Accession 0001213900-22-025289
CIK 0001176309other
Filed
May 9, 8:00 PM ET
Accepted
May 10, 5:32 PM ET
Size
5.3 KB
Accession
0001213900-22-025289
Insider Transaction Report
Form 4/AAmended
Mayer Arie
Director
Transactions
- Award
Common Stock
2022-01-03+6,000→ 6,000 total
Footnotes (2)
- [F1]Represents Restricted Stock Units ("RSUs") that will vest in 4 installments as follows: 1,500 shall vest on each of January 1, 2023, January 1, 2024, January 1, 2025 and January 1, 2026. The RSUs convert into the Issuer's Common Stock on a one-for-one basis.
- [F2]This amendment is being filed to correct an administrative error in the Form 4 filed by Dr. Mayer, which reported that 9,000 shares of common stock were beneficially owned by him following the reported transaction. Dr. Mayer beneficially owned 6,000 shares of common stock following the reported transaction.
Documents
Issuer
ORAMED PHARMACEUTICALS INC.
CIK 0001176309
Entity typeother
Related Parties
1- filerCIK 0001796583
Filing Metadata
- Form type
- 4/A
- Filed
- May 9, 8:00 PM ET
- Accepted
- May 10, 5:32 PM ET
- Size
- 5.3 KB